
Korro Bio, Inc.
Korro Bio, Inc. (KRRO)
WebsitePrice
Market cap
Next catalystBegin UCD patient dosing in ANCHOR Part 2 in H1 2027, subject to regulatory clearance to proceedKRRO-121 — ANCHOR Part 2, UCD patients · Trial initiationSEC filing ↗
Cash
Chart & Events
Core Clinical
PreINDP1P3FilingApproved
PreINDP1P2P3FilingApproved
Technology Summary
Scientific context
Detailed technology interpretation
Technology advantages
Clinical
Upcoming clinical milestones
PreINDP1P3FilingApproved
PreINDP1P2P3FilingApproved
Other pipelines
PreINDP1P2P3FilingApproved
PreINDP1P2P3FilingApproved
PreINDP1P2P3FilingApproved